Preventing Catheter-Related Bloodstream Infections
Thinking Outside the Checklist
- Eli N. Perencevich, MD, MS;
- Didier Pittet, MD, MS
- Author Affiliations: Departments of Epidemiology and Preventive Medicine, University of Maryland Medical Center, and VA Maryland Health Care System, University of Maryland School of Medicine, Baltimore (Dr Perencevich); Infection Control Program, University of Geneva Hospitals and Faculty of Medicine, World Health Organization World Alliance for Patient Safety, First Global Patient Safety Challenge, World Health Organization Headquarters, Geneva, Switzerland (Dr Pittet).
Since this article does not have an abstract, we have provided the first 150 words of the full text.
- KEYWORDS:
- CATHETER-RELATED INFECTIONS
- CROSS INFECTION
- INFECTION CONTROL
- METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
- QUALITY OF HEALTH CARE
- SEPSIS
The medical care system is at a crossroads in the control of health care–associated infections. For years, the status quo has been defined by scattered local success stories but an overall failure to protect patients from largely preventable infections. These infections have enormous human and economic costs, with an estimated 100 000 deaths and $6.5 billion in excess expenditure annually in the United States alone1,2 and estimates of 1.4 million patients affected daily worldwide.3,4 Catheter-related bloodstream infection is a leading contributor to health care–associated infection. Approximately 80 000 catheter-related bloodstream infections occur annually in US intensive care units (ICUs) and are associated with as many as 24 000 patient deaths.5 Each of these infections is estimated to have a mean attributable cost of $18 000 and an associated excess hospital stay of 12 days per episode.6
There are many reasons for this global epidemic of health …
